SEC Form 4 · accession 0001209191-18-021647
Clearside Biomedical, Inc. · CLSD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles A. Deignan
Officer — Chief Financial Officer
Period of report
Mar 23, 2018
Accepted (ET)
Mar 26, 2018 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001539029
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2018 | P | 500 | $11.79 | A | 66,356 | D |
Table II — derivative securities
No Table II lines on this filing.